CCL3 and Alzheimer disease: Furthermore, some studies have demonstrated that pharmacological inhibition of IL-1β, TNF-α, MCP-1, and MIP-1α expressions is closely associated with the improvement of OX-induced AD-like skin lesions in mice [29,35,36].